Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults

Clinical trial NCT07754045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07754045
Sponsor: Lumos Pharma
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity & Overweight

Start date: 2027-02-15
Primary completion: 2028-02-15
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.